Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Assertio Holdings Inc (ASRT)  
$0.96 0.09 (8.57%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,670,000
Market Cap: 90.88(M)
Last Volume: 940,193 Avg Vol: 714,677
52 Week Range: $0.754 - $7.66
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 246
  Page 4 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Moretti August J Chief Financial Officer & SVP   •       –      –    2017-04-02 4 D $12.55 $11,797 D/D (940) 41,785     -
   Vargas Thadd M Senior VP, BD   •       –      –    2017-04-02 4 D $12.55 $11,797 D/D (940) 91,567     -
   Staple Peter D Director   –       •      –    2017-03-31 4 OE $3.27 $49,050 I/I 15,000 99,403     -
   Higgins Arthur J President and CEOOfficer   •       •      –    2017-03-28 3 IO $0.00 $0 I/I 0 1,000     -
   Molinelli Gavin Director   –       •      –    2017-03-28 3 IO $0.00 $0 I/I 0 5,295,270     -
   Zenoff David B Director   –       •      –    2017-02-21 4 OE $1.49 $212,900 I/I 70,000 93,999     -
   Schoeneck James A President and CEO   •       •      –    2016-12-23 4 GA $0.00 $0 I/I 61,207 495,105     -
   Schoeneck James A President and CEO   •       •      –    2016-12-23 4 GD $0.00 $0 D/D 61,207 0     -
   Schoeneck James A President and CEO   •       •      –    2016-12-01 4 D $18.55 $1,239,010 D/D (66,793) 61,207     -
   Srinivas Rao SVP and Chief Medical Officer   •       –      –    2016-12-01 4 D $18.55 $88,910 D/D (4,793) 17,967     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-12-01 4 D $18.55 $201,323 D/D (10,853) 40,225     -
   Gosling Matthew M SVP, General Counsel   •       –      –    2016-12-01 4 D $18.55 $244,897 D/D (13,202) 78,317     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-12-01 4 D $18.55 $186,502 D/D (10,054) 90,007     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-11-14 4 AS $20.84 $104,200 D/D (5,000) 21,680     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-11-14 4 OE $12.69 $63,450 D/D 5,000 26,680     -
   Fogarty James P Director   –       •      –    2016-10-17 3 IO $0.00 $0 D/D 0 16,450     -
   Schoeneck James A President and CEO   •       •      –    2016-10-12 5 GD $0.00 $0 I/I 2,000 495,105     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-09-21 4 AS $25.00 $281,250 D/D (11,250) 73,086     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-08-10 4 AS $21.40 $107,000 D/D (5,000) 21,680     -
   Moretti August J Chief Financial Officer & SVP   •       –      –    2016-08-10 4 OE $12.69 $41,839 D/D 3,297 24,977     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-08-10 4 AS $20.92 $549,987 D/D (26,290) 84,336     -
   Schoeneck James A President and CEO   •       •      –    2016-06-06 4 GA $0.00 $0 I/I 38,163 435,898     -
   Schoeneck James A President and CEO   •       •      –    2016-06-06 4 GD $0.00 $0 D/D 38,163 0     -
   Vargas Thadd M Senior VP, BD   •       –      –    2016-05-23 4 AS $20.00 $300,000 D/D (15,000) 109,297     -
   Schoeneck James A President and CEO   •       •      –    2016-05-18 4 GD $0.00 $0 I/I 1,000 397,735     -
  246 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us